Topical antiinflammatory activity of an innovative aqueous formulation of actichelated® propolis vs two commercial propolis formulations
A novel aqueous commercial formulation of a new hydrophilic propolis product (Actichelated® Propolis, contained in 'LeniGola PropolEffect Spray Senza Alcohol'; Pharbenia, Milan, Italy) was evaluated for its topical antiinflammatory activity in comparison with a hydroglyceric propolis spray...
Saved in:
Published in: | Phytotherapy research Vol. 21; no. 9; pp. 823 - 826 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Chichester, UK
John Wiley & Sons, Ltd
01-09-2007
Wiley |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A novel aqueous commercial formulation of a new hydrophilic propolis product (Actichelated® Propolis, contained in 'LeniGola PropolEffect Spray Senza Alcohol'; Pharbenia, Milan, Italy) was evaluated for its topical antiinflammatory activity in comparison with a hydroglyceric propolis spray solution ('Propoli LeniGola Spray Senza Alcool'; Pharbenia, Milan, Italy) and a hydroalcohol preparation ('Propoli LeniGola Spray Forte'; Pharbenia, Milan, Italy). Actichelated® propolis (Actimex, Trieste, Italy) is a multicomposite material obtained with a patented technology, mechano-chemical activation, which application led to a new hydrosoluble form of propolis.Each propolis preparation provoked a dose-dependent inhibition of the croton oil-induced ear oedema in mice. Considering the administered doses of flavonoids, 'LeniGola PropolEffect Spray Senza Alcool' (ID₅₀ = 13.6 μL/cm², corresponding to 13.6 μg flavonoids/cm²) is slightly more active than the hydroglyceric formulation 'Propoli LeniGola Spray' (ID₅₀ = 13.7 μL/cm², corresponding to 20.6 μg flavonoids/cm²) and six times more active than the hydroalcohol preparation 'Propoli LeniGola Spray Forte' (ID₅₀ = 5.5 μL/cm², corresponding to 82.5 μg flavonoids/cm²). As a reference, 15 μL/cm² of the commercial sprays Tantum® Verde and Froben®, containing 37.5 or 45 μg of the non-steroidal antiinflammatory drugs benzidamine hydrochloride or flurbiprofen, induced 18% and 35% oedema inhibition, respectively. Copyright © 2007 John Wiley & Sons, Ltd. |
---|---|
Bibliography: | http://dx.doi.org/10.1002/ptr.2206 ArticleID:PTR2206 ark:/67375/WNG-9LN6F525-L istex:5CB99EE3A0E869836DCF4D9E91F07475BDD4BF83 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0951-418X 1099-1573 |
DOI: | 10.1002/ptr.2206 |